Israeli Prime Minister Benjamin Netanyahu said his government would do its utmost to blunt the effect of job cuts at Teva Pharmaceutical Industries Ltd as the debt-saddled company carries out its restructuring plan.
Netanyahu and Minister of Finance Moshe Kahlon are to meet this week with Teva chief executive officer Kare Schultz to try to “minimize the blow to workers,” according to an e-mailed statement from the prime minister’s office.
Netanyahu said he would do everything possible to prevent the closure of local plants and ensure that Teva, based near Tel Aviv, “will remain an Israeli company.”
Netanyahu stepped in after Schultz announced plans last week to slash 25 percent of Teva’s workforce and suspend dividends, aiming to cut US$3 billion in costs and whittle down a debt pile more than twice the size of Teva’s market capitalization.
Striking workers on Sunday idled Israel’s international airport, government offices, banks and stock market for half a day, pressing to scale back Teva’s plan to cut 14,000 jobs, including 1,700 in Israel.
The protesting employees tied up morning rush-hour traffic and burned tires outside a Jerusalem factory, while some barricaded themselves inside. Hundreds of Teva employees marched to Netanyahu’s office before Cabinet members arrived for their weekly meeting.
The government is considering a grant to Teva that would enable it to cut fewer Israeli jobs, the Haaretz newspaper said, without saying how it got the information.
In Israel, Teva had been viewed with pride for decades as the nation’s only corporate giant by global standards, with so many Israelis owning Teva shares that it is referred to as “the people’s stock.” One of the world’s biggest generic drugmakers, it is also one of Israel’s biggest employers. As a symbol of Israel’s entrepreneurial spirit, its meltdown is therefore seen as much more than just another failed business.
A walkout that the Histadrut labor federation called on Sunday in solidarity with Teva employees lasted until noon.
“Our factory is bleeding and the situation is bleak,” Teva union leader Itzik Ben-Simon told Israel Radio.
The company is monitoring the protests and seeking to minimize any effect on operations, spokesman Yonatan Beker said by telephone.
“Teva’s supply chain is evaluating its product supplies and production alternatives for all its products at any disrupted facilities, and will update its customers directly on the matter,” the company said in a statement.
Teva has been struggling since it paid almost US$41 billion last year to acquire Allergan PLC’s generics unit, a deal that failed to yield the anticipated sales boost. Compounding the problem is the loss of its monopoly on Copaxone, a multiple-sclerosis drug that at one point generated half of Teva’s profits.
Teva shares on Sunday rose as much as 2.7 percent in Tel Aviv trading, after jumping 13 percent on Thursday last week when Schultz outlined the restructuring plan. Teva’s US depositary receipts rose 10 percent on Thursday last week in New York and 8 percent the following day.
The drugmaker, whose expenses are to total US$16.1 billion this year, said most of the cost reduction is to take place next year.
It also is to record a restructuring charge of at least US$700 million, it said.
Schultz said his top priority is to bring Teva’s leverage below four times earnings before interest, taxes, depreciation and amortization by the end of 2020.
The ratio was 4.7 last quarter.
The proposals include paying down US$4 billion of bank loans within a “relatively short” period, he said.
Schultz, who was offered US$40 million in cash and stock to take the CEO job last month, swiftly instituted a management shakeup and announced plans to reorganize Teva’s generic and branded drug businesses into a single, streamlined entity.
‘SWASTICAR’: Tesla CEO Elon Musk’s close association with Donald Trump has prompted opponents to brand him a ‘Nazi’ and resulted in a dramatic drop in sales Demonstrators descended on Tesla Inc dealerships across the US, and in Europe and Canada on Saturday to protest company chief Elon Musk, who has amassed extraordinary power as a top adviser to US President Donald Trump. Waving signs with messages such as “Musk is stealing our money” and “Reclaim our country,” the protests largely took place peacefully following fiery episodes of vandalism on Tesla vehicles, dealerships and other facilities in recent weeks that US officials have denounced as terrorism. Hundreds rallied on Saturday outside the Tesla dealership in Manhattan. Some blasted Musk, the world’s richest man, while others demanded the shuttering of his
TIGHT-LIPPED: UMC said it had no merger plans at the moment, after Nikkei Asia reported that the firm and GlobalFoundries were considering restarting merger talks United Microelectronics Corp (UMC, 聯電), the world’s No. 4 contract chipmaker, yesterday launched a new US$5 billion 12-inch chip factory in Singapore as part of its latest effort to diversify its manufacturing footprint amid growing geopolitical risks. The new factory, adjacent to UMC’s existing Singapore fab in the Pasir Res Wafer Fab Park, is scheduled to enter volume production next year, utilizing mature 22-nanometer and 28-nanometer process technologies, UMC said in a statement. The company plans to invest US$5 billion during the first phase of the new fab, which would have an installed capacity of 30,000 12-inch wafers per month, it said. The
MULTIFACETED: A task force has analyzed possible scenarios and created responses to assist domestic industries in dealing with US tariffs, the economics minister said The Executive Yuan is tomorrow to announce countermeasures to US President Donald Trump’s planned reciprocal tariffs, although the details of the plan would not be made public until Monday next week, Minister of Economic Affairs J.W. Kuo (郭智輝) said yesterday. The Cabinet established an economic and trade task force in November last year to deal with US trade and tariff related issues, Kuo told reporters outside the legislature in Taipei. The task force has been analyzing and evaluating all kinds of scenarios to identify suitable responses and determine how best to assist domestic industries in managing the effects of Trump’s tariffs, he
Taiwan’s official purchasing managers’ index (PMI) last month rose 0.2 percentage points to 54.2, in a second consecutive month of expansion, thanks to front-loading demand intended to avoid potential US tariff hikes, the Chung-Hua Institution for Economic Research (CIER, 中華經濟研究院) said yesterday. While short-term demand appeared robust, uncertainties rose due to US President Donald Trump’s unpredictable trade policy, CIER president Lien Hsien-ming (連賢明) told a news conference in Taipei. Taiwan’s economy this year would be characterized by high-level fluctuations and the volatility would be wilder than most expect, Lien said Demand for electronics, particularly semiconductors, continues to benefit from US technology giants’ effort
RSS